⌘K

Login Start Free

Home/Filings/4/0001855763-22-000009

4//SEC Filing

DOCHERTY JOHN MARTIN 4

Accession 0001855763-22-000009

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 5:26 PM ET

Size

10.7 KB

Accession

0001855763-22-000009

Insider Transaction Report

Form 4

Period: 2022-08-29

Lexaria Bioscience Corp.LEXX

DOCHERTY JOHN MARTIN

DirectorPresident

Transactions

Award
Stock Options
2022-08-29+30,000→ 94,668 total
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (30,000 underlying)

Holdings

common shares
(indirect: Private Holding Company)
54,075
Stock Options
Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (18,334 underlying)
49,668
Stock Options
Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (18,000 underlying)
31,334
Stock Options
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (13,334 underlying)
13,334
Stock Options
Exercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (15,000 underlying)
64,668

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001638727

Filing Metadata

Form type: 4
Filed: Aug 28, 8:00 PM ET
Accepted: Aug 29, 5:26 PM ET
Size: 10.7 KB

View on SEC.gov